BCL2L1 and non-small cell lung carcinoma: We then found that the overexpression of miR-204 in cisplatin-resistant NSCLC cells increased the cellular level of both Bad-Bcl-heterodimers and Bad-Bcl-xl heterodimers through the suppression of CAV-1.